Jeffrey Closs is the founder of Ancora Heart. Ancora Heart has raised $151M in total funding. Latest round: Series B. Backed by Sands Capital.
Jeffrey Closs is the President and CEO of Ancora Heart, Inc., a Santa Clara-based developer of heart failure treatments, a role he has held since November 2015. He leads the company's efforts in advancing the AccuCinch System and oversees strategic direction and funding initiatives.
Full founder directory · Investor directory · Company funding database · Fundraising library